{
    "nct_id": "NCT06026254",
    "official_title": "Rollover Study to Continue IMSA101 Treatments in Patients With Advanced Treatment-Refractory Malignancies Previously Enrolled in the Phase I/IIA Safety and Efficacy Study of IMSA101",
    "inclusion_criteria": "1. Signed informed consent and mental capability to understand the informed consent\n2. Currently enrolled in parent protocol IMSA101-101 and is receiving IMSA101 treatment\n3. Deriving clinical benefit from study treatment, as determined by the investigator\n4. Must have fulfilled all required assessments in parent protocol IMSA101-101\n5. Male and female patients with reproductive potential must agree to use two forms of highly effective contraception throughout the study\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
    "exclusion_criteria": "1. Permanently discontinued from IMSA101 treatment in parent protocol IMSA101-101 for any reason other than enrollment in the rollover study\n2. Failure to meet the criteria specified in parent protocol IMSA101-101 for continued study treatment",
    "miscellaneous_criteria": ""
}